Article Details
Retrieved on: 2021-04-12 16:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lilly's monoclonal treatment bamlanivimab was the first neutralizing antibody to score FDA authorization against COVID-19. The antibody was OK'd in ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here